Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

Context The optimal management for men with prostate cancer (PCa) with unconventional
histology (UH) is unknown. The outcome for these cancers might be worse than for …

Intraductal carcinoma of the prostate (IDC‐P) most often appears associated with high‐
grade invasive prostate carcinoma (PCa), where it is believed to represent retrograde …

Simple Summary Most men with prostate cancer will live as long as those who do not have
prostate cancer. However, some men will die early of their disease due to a particular type of …

The fifth edition of the WHO Classification of Tumours of the Urinary and Male Genital
Systems encompasses several updates to the classification and diagnosis of prostatic …

Background Although the presence of intraductal carcinoma of the prostate (IDC‐P)
influences biochemical failure in radical prostatectomy patients, no data are available …

Simple Summary Prostate cancer is one of the most common male cancers. A more accurate
disease assessment is needed to better stratify patients' risks and guide treatment decisions …

Prostate cancer is a common malignancy, but only some tumors are lethal. Accurately
identifying these tumors will improve clinical practice and instruct research. Aggressive …

Background Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of
recurrence and survival with particular treatment response, yet no study has tested its …

Objective To determine the prevalence of intra‐patient inter‐metastatic heterogeneity based
on positron emission tomography (PET)/computed tomography (CT) in patients with …